Business1 outlet
Moderna Starts Phase 1 Trial of Experimental Ebola Vaccine
Moderna has initiated Phase 1 clinical trials for an experimental Ebola vaccine in response to the severe outbreak in the Democratic Republic of Congo. This marks the second vaccine candidate to advance to human testing against the specific strain responsible for the country's deadliest Ebola outbreak. The development represents an accelerated effort to combat the ongoing health crisis.
Readers say
How does this story lean?
Outlet ratings above are Trace's curated source map. Vote here (same as on the home feed) — one vote per browser, changeable anytime. Rate individual outlets in the coverage list below.
How does this lean?
Comments
0No comments yet. Say what you noticed in the coverage.
Trending